In this article, we take a look at two very up and coming stocks in Johnson & Johnson and Sarepta Therapeutics. Keep an eye out for Johnson & Johnson (NYSE JNJ) and Sarepta Therapeutics (NASDAQ SRPT). While at one hand, analysts are optimistic about Johnson & Johnson’s second quarter earnings, Sarepta Therapeutics would be looking to bounce back after some dismal showing recently. With J&J … Continue reading Biotech Stocks : Review of Johnson & Johnson and Sarepta Therapeutics